Organoids for cancer research

In the last decade, organoid technology has transitioned from an exciting prospect in basic research to a paradigm-shifting phenomenon that has shaped policy and changed the face of drug development. With their mainstream status becoming increasingly secure, the focus on organoid technology is shifting from their potential and validation to more practical aspects, such as their applications, establishing reproducibility, and selecting appropriate model types and production methods.

Nowhere is the impact of these technologies more important than cancer research, where these models are beginning to provide vital insights into the disease while serving as robust, insightful platforms for therapeutic development. This In Focus, supported by Sartorius, will explore the different types of tumor organoids, their production and their attributes, enabling researchers to familiarize themselves with the quirks and perks of the technology and select the best models for their research questions.